Alzheimer's & Cognition
Conference Coverage
TauRx still rooting for its methylene blue AD drug, despite controversial study results
SAN DIEGO – An anti-tau compound that has stirred scientific controversy for 8 years will continue along its developmental pathway at a much lower...
Conference Coverage
After full data release, experts say failed Alzheimer’s trial EXPEDITION 3 offers hopeful signals
SAN DIEGO – Solanezumab may have not have slowed the relentless march of Alzheimer’s disease, but it was a valuable proving ground of the amyloid...
Conference Coverage
Nonalcoholic fatty liver disease accelerates brain aging
TORONTO – NAFLD seems to accelerate physical brain aging by up to 7 years, according to a new subanalysis of the ongoing Framingham Heart Study....
Feature
Legislators commit to bipartisan support of Alzheimer’s funding
WASHINGTON - The nation's political sea-change won't wash Alzheimer's disease research funding offtrack, two legislators vowed at a Washington...
From the Editor
Are you neuroprotecting your patients? 10 Adjunctive therapies to consider
Recurrent episodes of psychosis, mania, or depression have been shown to be potentially neurodegenerative and associated with neurotoxicity due...
Feature
Antiamyloid solanezumab fails to slow decline in mild Alzheimer’s
Solanezumab, a monoclonal antibody that targets amyloid plaques, did not slow cognitive decline in patients with mild Alzheimer’s disease.
From the Journals
ADT not associated with increased risk of dementia in larger study
Treatment with androgen deprivation therapy (ADT) was not associated with an increased risk of dementia in a large, population-based study,...
Conference Coverage
VIDEO: Blood pressure and LDL lowering in elderly do not slow cognitive decline
NEW ORLEANS – Patients in their 70s and early 80s get the cardiovascular benefits of statin therapy without increased risk of cognitive decline....
Conference Coverage
Aerobic exercise improves depression-related cognitive impairment
VIENNA
From the Journals
Home-based intervention improves cognitive impairment in cancer survivors
A home-based intervention designed to address cognitive impairment in cancer survivors led to significant improvements in perceived cognitive...
Conference Coverage
Blood pressure changes and persistent hypertension elevate dementia risk
BALTIMORE - The impact of blood pressure on the risk of dementia in late life follows a U-shaped curve in which elevated mid-life and late-life...